Japan's Sawai Pharma to buy US generics maker

OSAKA — Sawai Pharmaceutical will buy the generics business of U.S. drugmaker Upsher-Smith Laboratories for $1.05 billion, the Japanese company said Thursday, eager to make up for lost time after its first push into the American market stalled.
( read original story …)


Related Post

Japan’s Abe announces snap election amid ‘national...
views 39
Japanese Prime Minister Shinzo Abe said he would d...
Norway’s oil fund makes first Asian property inves...
views 67
Norway’s $1tn oil fund is eyeing further property ...
Why Nikkei 225 Stocks Have Dropped This Week
views 47
More on that here. Earlier this week, Japanese sto...
Japan demands talks with U.K. government over Brex...
views 127
“Japanese companies are not leaving, they li...
U.N. report on press freedom in Japan based on mis...
views 127
ジュネーブの国連人権理事会で、「表現の自由」に関する特別報告者のデービッド・ケイ氏が、日本についての...
JAL Business Class Haneda SFO
views 170
We flew in from Osaka, so we already had our board...
McCann Health Japan opens new office in Osaka
views 112
Osaka City as the base for its health communicatio...
Nissan reveals blooper in Japan production
views 79
YOKOHAMA: Nissan Motor said it would temporarily h...
Japan lender Mizuho to launch fintech venture
views 134
Daisuke Yamada, Mizuho's chief digital innovation ...
Japanese stocks eke out gains in holiday-thinned t...
views 164
TOKYO, April 17 Japanese stocks eked out small gai...